CVR: 39904276
Secondary names: Villus Therapeutics ApS
Bainan Biotech ApS was a Danish company of the type Anpartsselskab based in København N, founded in 2018. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company's owners include MM Rosenkilde ApS, B Hartmann Holding ApS and JJ Holst ApS. In 2023, the company reported a gross profit of DKK -382,113 and a net result of DKK -2,671,977 compared with DKK -3,128,882 the year before. Equity amounted to DKK -15,215,743.
Selskabets formål er forskning og udvikling af produkter inden for medicinindustrien samt al virksomhed, som efter bestyrelsens skøn har forbindelse hermed.
Indkaldelse til fordringsprøvelse i konkursboet Bainan Biotech ApS, Sø- og Handelsretten, sagsnr. K 345/25-K.
Source: Statstidende — updated daily
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorCompared to 1.054 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
On July 4, 2026, Bainan Biotech ApS was placed under bankruptcy proceedings.
On June 4, 2026, a notice regarding Bainan Biotech ApS was published in Statstidende: Indkaldelse til fordringsprøvelse (S02062026-341).
As of February 24, 2025, EY Godkendt Revisionspartnerselskab has stepped down as auditor of Bainan Biotech ApS.
As of February 24, 2025, Mette Marie Rosenkilde has left the board of directors of Bainan Biotech ApS.
As of February 24, 2025, Jens Juul Holst has left the board of directors of Bainan Biotech ApS.
As of February 24, 2025, Bolette Hartmann has left the board of directors of Bainan Biotech ApS.
As of February 24, 2025, Bolette Hartmann has stepped down as adm. dir. of Bainan Biotech ApS.
As of July 8, 2024, Vivopharm Holding ApS is registered as an owner of Bainan Biotech ApS with an ownership share of 10%.
As of July 8, 2024, J Kryger Holding ApS is registered as an owner of Bainan Biotech ApS with an ownership share of 10%.
Bainan Biotech ApS has published its annual report for 2023. Gross profit came to DKK -382,113, and the net result was DKK -2,671,977.
Bainan Biotech ApS has published its annual report for 2022. Gross profit came to DKK -1,230,180, and the net result was DKK -3,128,882.
As of June 29, 2023, Bolette Hartmann is registered as adm. dir. of Bainan Biotech ApS.
As of June 29, 2023, Tue Alexander Emborg has stepped down as adm. dir. of Bainan Biotech ApS.
As of June 1, 2023, Tue Alexander Emborg is registered as adm. dir. of Bainan Biotech ApS.
As of June 1, 2023, Bolette Hartmann has stepped down as adm. dir. of Bainan Biotech ApS.
As of May 15, 2023, Arvind Mansha Hundal has left the board of directors of Bainan Biotech ApS.
Bainan Biotech ApS has published its annual report for 2021. Gross profit came to DKK -3,709,804, and the net result was DKK -9,063,823.
As of November 10, 2021, Bolette Hartmann is registered as adm. dir. of Bainan Biotech ApS.
As of November 10, 2021, Ditte Riber has stepped down as adm. dir. of Bainan Biotech ApS.
Bainan Biotech ApS has published its annual report for 2020. Gross profit came to DKK 1,952,827, and the net result was DKK -509,902.
As of May 7, 2021, Ditte Riber is registered as adm. dir. of Bainan Biotech ApS.
As of May 7, 2021, Tue Alexander Emborg has stepped down as director of Bainan Biotech ApS.
As of December 1, 2020, Arvind Mansha Hundal has joined the board of directors of Bainan Biotech ApS.
As of November 15, 2020, EY Godkendt Revisionspartnerselskab has been appointed auditor of Bainan Biotech ApS.
As of November 15, 2020, Mette Marie Rosenkilde has joined the board of directors of Bainan Biotech ApS.
As of November 14, 2020, Mette Marie Rosenkilde has left the board of directors of Bainan Biotech ApS.
Bainan Biotech ApS has published its interim report for the period September 27, 2018 – December 31, 2019.
As of September 27, 2018, Mette Marie Rosenkilde has joined the board of directors of Bainan Biotech ApS.
As of September 27, 2018, Jens Juul Holst has joined the board of directors of Bainan Biotech ApS.
As of September 27, 2018, Bolette Hartmann has joined the board of directors of Bainan Biotech ApS.
As of September 27, 2018, Tue Alexander Emborg is registered as director of Bainan Biotech ApS.
As of September 27, 2018, MM Rosenkilde ApS is registered as an owner of Bainan Biotech ApS with an ownership share of 25%.
As of September 27, 2018, B Hartmann Holding ApS is registered as an owner of Bainan Biotech ApS with an ownership share of 25%.
As of September 27, 2018, JJ Holst ApS is registered as an owner of Bainan Biotech ApS with an ownership share of 10%.
Bainan Biotech ApS was founded on September 27, 2018.
Companies in the same industry and area
CVR 45436497
CVR 46543912
CVR 40766383
CVR 42731323
CVR 38599119
companydata.dk